FDA 483 - Daniel Norman, M.D. - October 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspection of Daniel Norman, M.D., Clinical Investigator, identified a critical failure in maintaining accurate and complete case histories for a clinical study involving an investigational drug. The firm failed to properly document adverse events for multiple subjects in the required system, despite these events being noted in the source records. This indicates a significant lapse in adherence to study protocol and data integrity during clinical investigations.
ID · 5bafc539-7e39-4606-bd4b-e1b23a9c6bea